Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group.

× No keyword cloud information.

8 in total

Review 1. Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors: P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal: Clin Pharmacokinet Date: 1992-05 Impact factor: 6.447

Authors: W R Waddell
Journal: Ann Surg Date: 1975-03 Impact factor: 12.969

Authors: H L Parnes; J S Abrams; N S Tchekmedyian; N Tait; J Aisner
Journal: Breast Cancer Res Treat Date: 1991-08 Impact factor: 4.872

Authors: M De Lena; C Brambilla; P Valagussa; G Bonadonna
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

Authors: G Cocconi
Journal: Breast Cancer Res Treat Date: 1994 Impact factor: 4.872

Authors: M Salimtschik; H T Mouridsen; J Loeber; E Johansson
Journal: Cancer Chemother Pharmacol Date: 1980 Impact factor: 3.333

Authors: D W Hedley; M Christie; R P Weatherby; I D Caterson
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

Authors: Bruce D Keith
Journal: BMC Cancer Date: 2008-03-28 Impact factor: 4.430

8 in total